Korean J Dermatol.  1996 Dec;34(6):980-983.

The Use of Hydroxychloroquine in Patients with Pemphigus Erythematosus

Affiliations
  • 1Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea.

Abstract

Pemphigus erythematosus (PE) is a superficial type of pemphigus, which can be aggravated by sunlight (espicially UV light). Because of the known side effects of corticosteroids, we evaluated the efficacy of hydroxychloroquine as a corticosteroid-sparing agent and/or the effect of a single-drug regimen in two patients with PE with photosensitivity. We obtained a good therapeutic response with hydroxychloroquine in these two patients with PE. This drug could be used in selected patients with pemphigus who are prednisolone/ immunosuppressive-resistant or who have certain degrees of photosensitivity.

Keyword

Hydroxychloroquine; Pemphigus erythematosus

MeSH Terms

Adrenal Cortex Hormones
Humans
Hydroxychloroquine*
Pemphigus*
Sunlight
Adrenal Cortex Hormones
Hydroxychloroquine
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr